Propafenone

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Propafenone" – news · newspapers · books · scholar · JSTOR (May 2019) (Learn how and when to remove this message)

Propafenone

Clinical data
Pronunciation	/proʊˈpæfɪnoʊn/ proh-PAF-i-nohn
Trade names	Rythmol, Rytmonorm, others
AHFS/Drugs.com	Monograph
MedlinePlus	a698002
License data	US DailyMed: Propafenone
Routes of administration	By mouth
ATC code	C01BC03 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Protein binding	97%
Elimination half-life	2–10 hours
Identifiers
IUPAC name 1-{2-[2-Hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one
CAS Number	54063-53-5 Y
PubChem CID	4932
IUPHAR/BPS	2561
DrugBank	DB01182 Y
ChemSpider	4763 Y
UNII	68IQX3T69U
KEGG	D08435 Y
ChEMBL	ChEMBL631 Y
CompTox Dashboard (EPA)	DTXSID9045184
ECHA InfoCard	100.053.578
Chemical and physical data
Formula	C21H27NO3
Molar mass	341.451 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(c1ccccc1OCC(O)CNCCC)CCc2ccccc2
InChI InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3 Y Key:JWHAUXFOSRPERK-UHFFFAOYSA-N Y
(verify)

Propafenone, sold under the brand name Rythmol among others, is a class 1c anti-arrhythmic medication, which is used to treat illnesses associated with rapid heart beat such as atrial and ventricular arrhythmias.